期刊语言：英语

出版地区：德国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：https://www.springer.com/journal/418/

3、投稿网址：https://www.editorialmanager.com/hacb

4、官网邮箱：如下。

5、期刊刊期：月刊，一年出版十二期。

2021年4月26日星期一

期刊邮箱【官网信息】

Contact the journal

Submission-related enquiries

Queries about submission issues, peer review process, or the status of your manuscript should be sent to Madan Ellappan (Madan.Ellappan@springernature.com).

Publication-related enquiries

Queries about accepted manuscripts in production or post-publication corrections should be sent to Vasumathi Ashok Kumar (vasumathi.ashok@springernature.com).

Other editorial enquiries

Any other queries about the journal or presubmission enquiries should be sent to Rahan Nazeer (Rahan.Nazeer@springernature.com).

投稿须知【官网信息】

Submission guidelines

Instructions for Authors

Histochemistry and Cell Biology is a journal devoted specifically to the field of molecular histology and cell biology. Original Articles and Short Communications dealing with the localization and identification of molecular components, metabolic activities and cell biological aspects of cells and tissues will be published as well as Review Articles. Papers are also welcome that make a substantial contribution to the development, application, and/or evaluation of methods and probes that can be used in the entire area of histochemistry and cell biology. Preference will be given to studies involving experimental approaches and/or a variety of different methods that help to characterize and quantify molecular constituents, dynamic properties and functional aspects of cellular and extracellular structures. Papers should be as concise as possible.

This is the official journal of the Society for Histochemistry (www.histochemistry.eu).

MANUSCRIPT TYPES

Original articles: There is no strict page limit, but we advise a maximum length of up to 20 printed pages (approx. 95,000 characters including references, not counting spaces). Likewise, there is no strict figure limit, but we advise a maximum number of 10 figures. Most importantly, paper length and content must be appropriate. Extensive tables, procedures, computer programs or animated graphics should be presented in form of Electronic Supplementary Material.

Short Communications (SC): The length of a SC is limited to approx. 20,000 characters (not counting spaces), which does NOT include the Materials and methods. SC are limited to five (5) figures. Supplemental material is limited to three (3) figures. Note that the Results and Discussion must be combined.

Reviews: Should address issues relevant to a wide readership and intelligible to non-specialists. We advise a maximum length of up to 20 printed pages (approx. 12000 words not including references). There is no strict figure limit, but we advise a maximum number of 10 figures.

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

Author information

The name(s) of the author(s)

The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country

A clear indication and an active e-mail address of the corresponding author

If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Abstract

Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.

For life science journals only (when applicable)

Trial registration number and date of registration

Trial registration number, date of registration followed by “retrospectively registered”

Keywords

Please provide 4 to 6 keywords which can be used for indexing purposes.

Declarations

All manuscripts must contain the following sections under the heading 'Declarations'.

If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.

To be used for all articles, including articles with biological applications

Funding (information that explains whether and by whom the research was supported)

Conflicts of interest/Competing interests (include appropriate disclosures)

Availability of data and material (data transparency)

Code availability (software application or custom code)

Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)

Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals

Ethics approval (include appropriate approvals or waivers)

Consent to participate (include appropriate statements)

Consent for publication (include appropriate statements)

Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.

Specific Remarks:

IntroductionSuccinct, no subheadings.

Materials and methodsShould follow the Introduction and should provide enough information to permit repetition of the experimental work.

Policy on Antibody ValidationAny manuscript in which antibody-based data are presented must provide evidence for specificity of the antibody. If the manufacturer of a commercially purchased antibody has provided proof of validation on the technical specifications insert, referring to this information will suffice. In the absence of such documentation, one (or more) of the following methods as recommended by an ad hoc International Working group for Antibody Validation1 must be included in the Materials and methods section:(1) Genetic – target protein expression eliminated or reduced by genome editing or siRNA(2) Orthogonal- target protein expression compared with non-antibody method (for instance, in situ hybridization or mass spectrometry)(3) Independent antibody – compare expression with a second antibody against target of interest, but recognizing non-overlapping epitopes(4) Tagged protein expression – express target protein with a tag in cultured cells; demonstrate overlap with antibody staining pattern(5) IMS – target protein captured by antibody, followed by analysis by MSIn addition to these recommended antibody validation methods, providing a Western blot as a preliminary indicator demonstrating that the antibody recognizes a correctly sized band, as well as known negative and known positive target tissues would be further valuable controls. Importantly, simply omitting the primary antibody is not considered a control for antibody specificity; it only serves to determine levels of non-specific binding of secondary antibodies.1 Uhlen M, Bandrowski A, Carr S, Edwards A, Ellenberg J, Lundberg E, Rimm DL, Rodriguez H, Hiltke T, Snyder M, Yamamoto T (2016) A proposal for validation of antibodies.. Nat Meth 13:823-827.

Results and DiscussionEach may be divided by subheadings. Symbols and names for genetic loci, alleles, DNA and RNA should be italicized. Nonstandard abbreviations should be defined when first used in the text. All text should be double spaced.

Text

Text Formatting

Manuscripts should be submitted in Word.

The text of a research paper should be divided into Introduction, Materials and Methods, Results, Discussion, Acknowledgements, Conflict of Interest, and References.

Materials and Methods must include statement of Human and Animal Rights.

Use a normal, plain font (e.g., 10-point Times Roman) for text.

Use italics for emphasis.

Use the automatic page numbering function to number the pages.

Do not use field functions.

Use tab stops or other commands for indents, not the space bar.

Use the table function, not spreadsheets, to make tables.

Use the equation editor or MathType for equations.

Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).

Manuscripts with mathematical content can also be submitted in LaTeX.

LaTeX macro package (Download zip, 188 kB)

Headings

Please use no more than three levels of displayed headings.

Abbreviations

Abbreviations should be defined at first mention and used consistently thereafter.

Footnotes

Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.

Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.

Always use footnotes instead of endnotes.

Acknowledgments and Funding Information

Acknowledgments of people, grants, funds, etc. should be placed in a separate section on the title page. The names of funding organizations should be written in full. In addition, please provide the funding information in a separate step of the submission process in the peer review system. Funder names should preferably be selected from the standardized list you will see during submission. If the funding institution you need is not listed, it can be entered as free text. Funding information will be published as searchable metadata for the accepted article, whereas acknowledgements are published within the paper.

References

Citation

Cite references in the text by name and year in parentheses. Some examples:

Negotiation research spans many disciplines (Thompson 1990).

This result was later contradicted by Becker and Seligman (1996).

This effect has been widely studied (Abbott 1991; Barakat et al. 1995a, b; Kelso and Smith 1998; Medvec et al. 1999, 2000).

Reference list

The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text.

Reference list entries should be alphabetized by the last names of the first author of each work. Please alphabetize according to the following rules: 1) For one author, by name of author, then chronologically; 2) For two authors, by name of author, then name of coauthor, then chronologically; 3) For more than two authors, by name of first author, then chronologically.

If available, please always include DOIs as full DOI links in your reference list (e.g. “https://doi.org/abc”).

Journal article

Gamelin FX, Baquet G, Berthoin S, Thevenet D, Nourry C, Nottin S, Bosquet L (2009) Effect of high intensity intermittent training on heart rate variability in prepubescent children. Eur J Appl Physiol 105:731-738. https://doi.org/10.1007/s00421-008-0955-8

Ideally, the names of all authors should be provided, but the usage of “et al” in long author lists will also be accepted:

Smith J, Jones M Jr, Houghton L et al (1999) Future of health insurance. N Engl J Med 965:325–329

Article by DOI

Slifka MK, Whitton JL (2000) Clinical implications of dysregulated cytokine production. J Mol Med. https://doi.org/10.1007/s001090000086

Book

South J, Blass B (2001) The future of modern genomics. Blackwell, London

Book chapter

Brown B, Aaron M (2001) The politics of nature. In: Smith J (ed) The rise of modern genomics, 3rd edn. Wiley, New York, pp 230-257

Online document

Cartwright J (2007) Big stars have weather too. IOP Publishing PhysicsWeb. http://physicsweb.org/articles/news/11/6/16/1. Accessed 26 June 2007

Dissertation

Trent JW (1975) Experimental acute renal failure. Dissertation, University of California

Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see

ISSN LTWA

If you are unsure, please use the full journal title.

Tables

All tables are to be numbered using Arabic numerals.

Tables should always be cited in text in consecutive numerical order.

For each table, please supply a table caption (title) explaining the components of the table.

Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.

Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.

Artwork and Illustrations Guidelines

Electronic Figure Submission

Supply all figures electronically.

Indicate what graphics program was used to create the artwork.

For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MSOffice files are also acceptable.

Vector graphics containing fonts must have the fonts embedded in the files.

Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.

Line Art

……